Division of Pulmonary, Critical Care & Sleep Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
Sleep. 2019 Mar 1;42(3). doi: 10.1093/sleep/zsy256.
To better understand the inter-individual differences in neurobehavioral impairment in obstructive sleep apnea (OSA) and its treatment with continuous positive airway pressure (CPAP), we examined how changes in sleep electroencephalography (EEG) slow waves were associated with next-day psychomotor vigilance test (PVT) performance.
Data from 28 OSA subjects (Apnea-Hypopnea Index with 3% desaturation and/or with an associated arousal [AHI3A] > 15/hour; AHI3A = sum of all apneas and hypopneas with 3% O2 desaturation and/or an EEG arousal, divided by total sleep time [TST]), who underwent three full in-lab nocturnal polysomnographies (NPSGs: chronic OSA, CPAP-treated OSA, and acute OSA), and 19 healthy sleepers were assessed. Four 20-minute PVTs were performed after each NPSG along with subjective and objective assessment of sleepiness. Three EEG metrics were calculated: K-complex (KC) Density (#/minute of N2 sleep), change in slow-wave activity in 1-second envelopes surrounding KCs (ΔSWAK), and relative frontal slow-wave activity during non-rapid eye movement (NREM) (%SWA).
CPAP treatment of OSA resulted in a decrease in KC Density (chronic: 3.9 ± 2.2 vs. treated: 2.7 ± 1.1; p < 0.01; mean ± SD) and an increase in ΔSWAK (chronic: 2.6 ± 2.3 vs. treated: 4.1 ± 2.4; p < 0.01) and %SWA (chronic: 20.9 ± 8.8 vs. treated: 26.6 ± 8.6; p < 0.001). Cross-sectionally, lower ΔSWAK values were associated with higher PVT Lapses (chronic: rho = -0.55, p < 0.01; acute: rho = -0.46, p = 0.03). Longitudinally, improvement in PVT Lapses with CPAP was associated with an increase in ΔSWAK (chronic to treated: rho = -0.48, p = 0.02; acute to treated: rho = -0.5, p = 0.03). In contrast, OSA severity or global sleep quality metrics such as arousal index, NREM, REM, or TST were inconsistently associated with PVT Lapses.
Changes in EEG slow waves, in particular ∆SWAK, explain inter-individual differences in PVT performance better than conventional NPSG metrics, suggesting that ΔSWAK is a night-time correlate of next-day vigilance in OSA.
为了更好地理解阻塞性睡眠呼吸暂停(OSA)患者神经行为障碍的个体间差异及其持续气道正压通气(CPAP)治疗的效果,我们研究了睡眠脑电图(EEG)慢波变化与次日精神警觉性测试(PVT)表现之间的关系。
共纳入 28 名 OSA 患者(3%血氧饱和度降低和/或伴有觉醒的呼吸暂停-低通气指数[AHI3A]>15/小时;AHI3A=所有呼吸暂停和低通气伴有 3%血氧饱和度降低和/或 EEG 觉醒的总和,除以总睡眠时间[TST]),他们接受了 3 次完整的实验室夜间多导睡眠图(NPSG:慢性 OSA、CPAP 治疗的 OSA 和急性 OSA)和 19 名健康睡眠者。在每次 NPSG 后进行 4 次 20 分钟的 PVT,并对睡眠不足和客观评估进行评估。计算了 3 个 EEG 指标:K-复合(KC)密度(N2 睡眠的每分钟数量[#/分钟])、围绕 KC 的慢波活动在 1 秒包络中的变化(ΔSWAK)和非快速眼动(NREM)期间的相对额部慢波活动(%SWA)。
CPAP 治疗 OSA 导致 KC 密度降低(慢性:3.9±2.2 与治疗:2.7±1.1;p<0.01;平均值±标准差)和 ΔSWAK 增加(慢性:2.6±2.3 与治疗:4.1±2.4;p<0.01)和 %SWA(慢性:20.9±8.8 与治疗:26.6±8.6;p<0.001)。横向研究显示,较低的 ΔSWAK 值与较高的 PVT 失误(慢性:rho=-0.55,p<0.01;急性:rho=-0.46,p=0.03)相关。纵向研究显示,CPAP 治疗时 PVT 失误的改善与 ΔSWAK 的增加相关(慢性到治疗:rho=-0.48,p=0.02;急性到治疗:rho=-0.5,p=0.03)。相比之下,OSA 严重程度或全局睡眠质量指标,如觉醒指数、NREM、REM 或 TST,与 PVT 失误的相关性不一致。
脑电图慢波的变化,特别是 ΔSWAK,比传统的 NPSG 指标更好地解释了 PVT 表现的个体间差异,这表明 ΔSWAK 是 OSA 患者次日警觉性的夜间相关指标。